VBI Net Income from 2010 to 2024
| VBIV Stock | USD 0.61 0.01 1.61% |
Net Loss | First Reported 1998-03-31 | Previous Quarter -20.4 M | Current Value -13 K | Quarterly Volatility 12 M |
Check VBI Vaccines financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VBI main balance sheet or income statement drivers, such as Selling General Administrative of 51.6 M, Total Revenue of 9.1 M or Other Operating Expenses of 93 M, as well as many exotic indicators such as Price To Sales Ratio of 1 K, Dividend Yield of 0.0 or PTB Ratio of 1.3 K. VBI financial statements analysis is a perfect complement when working with VBI Vaccines Valuation or Volatility modules.
VBI | Net Income |
Latest VBI Vaccines' Net Income Growth Pattern
Below is the plot of the Net Income of VBI Vaccines over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in VBI Vaccines financial statement analysis. It represents the amount of money remaining after all of VBI Vaccines operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is VBI Vaccines' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VBI Vaccines' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (92.84 M) | 10 Years Trend |
|
Net Income |
| Timeline |
VBI Net Income Regression Statistics
| Arithmetic Mean | (49,538,629) | |
| Coefficient Of Variation | (78.78) | |
| Mean Deviation | 31,091,924 | |
| Median | (47,286,000) | |
| Standard Deviation | 39,025,128 | |
| Sample Variance | 1523T | |
| Range | 140.7M | |
| R-Value | (0.83) | |
| Mean Square Error | 508.8T | |
| R-Squared | 0.69 | |
| Significance | 0.0001 | |
| Slope | (7,247,447) | |
| Total Sum of Squares | 21321.4T |
VBI Net Income History
Other Fundumenentals of VBI Vaccines
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
VBI Vaccines Net Income component correlations
About VBI Vaccines Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include VBI Vaccines income statement, its balance sheet, and the statement of cash flows. VBI Vaccines investors use historical funamental indicators, such as VBI Vaccines's Net Income, to determine how well the company is positioned to perform in the future. Although VBI Vaccines investors may use each financial statement separately, they are all related. The changes in VBI Vaccines's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on VBI Vaccines's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on VBI Vaccines Financial Statements. Understanding these patterns can help to make the right decision on long term investment in VBI Vaccines. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -92.8 M | -88.2 M | |
| Net Loss | -114 M | -108.3 M | |
| Net Loss | -102 M | -96.9 M | |
| Net Loss | (0.01) | (0.01) | |
| Net Income Per E B T | 1.43 | 1.44 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VBI Vaccines in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VBI Vaccines' short interest history, or implied volatility extrapolated from VBI Vaccines options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports:Check out the analysis of VBI Vaccines Correlation against competitors. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for VBI Stock analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.79) | Revenue Per Share 0.689 | Quarterly Revenue Growth 19.896 | Return On Assets (0.29) | Return On Equity (2.20) |
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.